Answers are grounded in this paper and cite their sources.
Commentary on an RCT investigating esketamine's effect on postpartum depression, suggesting enhancements for future studies.
Editor, We read with great interest the recent multicentre randomised controlled trial (RCT) by Chu et al.,1 which explored the peri-operative administration of esketamine to prevent postpartum depression (PPD) in primiparae. This study provides clinically meaningful insights, confirming the short-term preventive effect of esketamine in women without antenatal depressive symptoms, with an acceptable safety profile. We commend that the authors contribute valuable evidence in a field with a substantial unmet need. However, from the perspective of refining the study's methodology and enhancing the robustness of its findings, we propose the following constructive suggestions for future research. Firstly, caesarean section is one of the surgeries with a high incidence of postoperative pain,2,3 and primiparae typically experience more significant postoperative pain compared to multiparae.4 In this study, the control group only assessed pain using the Numeric Rating Scale (NRS) at rest, with generally low scores at all time points. While this result suggests that sufentanil alone provides good baseline postoperative analgesia, additional data on the use of rescue analgesics, as well as detailed information on opioid-related adverse reactions such as nausea, vomiting, and sleep disturbances, would enable a more comprehensive assessment of analgesic efficacy. It would also help mitigate potential confounding effects of these side effects on Edinburgh Postnatal Depression Scale (EPDS) scores. To further strengthen the validity of the findings, future studies could incorporate more sensitive pain indicators, such as movement-evoked and cough-induced pain. Additionally, we noticed a potential typographical error in Fig. 3(c), which shows 24-h postoperative cumulative sufentanil consumption. The dose unit is labelled as ‘mg’, but it should be ‘μg’. Correcting this typo would help avoid misinterpretation of the study results. Secondly, the absence of haemodynamic monitoring data during and after esketamine administration warrants attention. Given the dual influence of neuraxial anaesthesia-induced hypotension and esketamine's sympathomimetic properties, the inclusion of haemodynamic variables, such as mean arterial pressure (MAP) and heart rate (HR), would contribute substantially to a more comprehensive safety profile. Therefore, a more detailed safety analysis is necessary. In terms of eligibility criteria, we recommend adjusting ‘pregnancy-induced hypertension’ to ‘hypertensive disorders of pregnancy (HDP)’, a more precise term that encompasses chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and superimposed preeclampsia.5 Such a change would more accurately identify high-risk patients who are particularly vulnerable to cardiovascular complications from esketamine use. Furthermore, we suggest considering the exclusion of individuals with a personal or familial psychiatric history, especially those with mood or psychotic disorders, to enhance sample homogeneity and avoid potential confounding factors. The 42-day postpartum period is a well recognised peak window for postpartum depression (PPD) symptoms, and is widely used as an assessment endpoint in relevant clinical studies.6,7 Thus, we suggest that the authors add a 42-day EPDS follow-up to future studies to strengthen the robustness of the conclusions and enhance their clinical applicability. In summary, Chu et al.'s study offers valuable evidence in support of peri-operative esketamine as a preventive strategy for PPD.1 We thank the authors for their important contributions. Incorporating pain and safety metrics, refined eligibility criteria, and a 42-day EPDS follow-up could further strengthen future research in this important field.
No takes yet. Share an insight, caveat, or question.
Wáng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: